Arcosa, Inc. Files 8-K Report
Ticker: ACA · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1739445
| Field | Detail |
|---|---|
| Company | Arcosa, INC. (ACA) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01, $600.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financial-reporting
Related Tickers: ACA
TL;DR
Arcosa filed a routine 8-K, no major news.
AI Summary
On August 12, 2024, Arcosa, Inc. filed an 8-K report to disclose information regarding Regulation FD and financial statements. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.
Why It Matters
This filing serves as a standard disclosure for Arcosa, Inc., informing the public about regulatory compliance and financial reporting, which is essential for investor transparency.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Arcosa, Inc. (company) — Registrant
- August 12, 2024 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- 500 N. Akard Street, Suite 400 Dallas, Texas 75201 (address) — Principal Executive Offices
- 972-942-6500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Arcosa, Inc.?
The primary purpose of this 8-K filing is to disclose information related to Regulation FD and to report on financial statements and exhibits, as of August 12, 2024.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is August 12, 2024.
Where are Arcosa, Inc.'s principal executive offices located?
Arcosa, Inc.'s principal executive offices are located at 500 N. Akard Street, Suite 400, Dallas, Texas 75201.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the state of incorporation for Arcosa, Inc.?
Arcosa, Inc. is incorporated in Delaware.
Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 9.7 · Accepted 2024-08-15 16:16:29
Key Financial Figures
- $0.01 — ange on which registered Common Stock ($0.01 par value) ACA New York Stock Exchange
- $600.0 million — ing of its offering (the "Offering") of $600.0 million in aggregate principal amount of 6.875%
Filing Documents
- aca-20240812.htm (8-K) — 27KB
- exh991pressrelease-pricing.htm (EX-99.1) — 17KB
- aca-20240812_g1.jpg (GRAPHIC) — 25KB
- image2a.jpg (GRAPHIC) — 25KB
- 0001739445-24-000123.txt ( ) — 279KB
- aca-20240812.xsd (EX-101.SCH) — 2KB
- aca-20240812_def.xml (EX-101.DEF) — 14KB
- aca-20240812_lab.xml (EX-101.LAB) — 25KB
- aca-20240812_pre.xml (EX-101.PRE) — 15KB
- aca-20240812_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On August 12, 2024, Arcosa, Inc. ("Arcosa") issued a press release announcing the pricing of its offering (the "Offering") of $600.0 million in aggregate principal amount of 6.875% senior notes due 2032 (the "Notes"). A copy of the press release announcing the pricing of the Offering is attached as Exhibit 99.1 to this report on Form 8-K and is incorporated by reference herein. The information in Item 7.01 of this report (including Exhibit 99.1) is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing. Additionally, the submission of this Item 7.01 is not an admission of the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD. This report does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Arcosa, Inc. Press Release, dated August 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Arcosa, Inc. (Registrant) August 15, 2024 By: /s/ Gail M. Peck Name: Gail M. Peck Title: Chief Financial Officer